IL116065A - Polycyclic 1, 2, 5-thiadiazole compounds, their preparation and pharmaceutical compositions containing them - Google Patents

Polycyclic 1, 2, 5-thiadiazole compounds, their preparation and pharmaceutical compositions containing them

Info

Publication number
IL116065A
IL116065A IL11606595A IL11606595A IL116065A IL 116065 A IL116065 A IL 116065A IL 11606595 A IL11606595 A IL 11606595A IL 11606595 A IL11606595 A IL 11606595A IL 116065 A IL116065 A IL 116065A
Authority
IL
Israel
Prior art keywords
compound
compound according
alkyl
formula
preceeding
Prior art date
Application number
IL11606595A
Other languages
English (en)
Other versions
IL116065A0 (en
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of IL116065A0 publication Critical patent/IL116065A0/xx
Publication of IL116065A publication Critical patent/IL116065A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL11606595A 1994-11-21 1995-11-20 Polycyclic 1, 2, 5-thiadiazole compounds, their preparation and pharmaceutical compositions containing them IL116065A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK132494 1994-11-21

Publications (2)

Publication Number Publication Date
IL116065A0 IL116065A0 (en) 1996-01-31
IL116065A true IL116065A (en) 2001-01-11

Family

ID=8103590

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11606595A IL116065A (en) 1994-11-21 1995-11-20 Polycyclic 1, 2, 5-thiadiazole compounds, their preparation and pharmaceutical compositions containing them

Country Status (13)

Country Link
US (1) US5741788A (de)
EP (1) EP0793665B1 (de)
JP (1) JPH10509154A (de)
AT (1) ATE205499T1 (de)
AU (1) AU3978095A (de)
DE (1) DE69522706T2 (de)
DK (1) DK0793665T3 (de)
ES (1) ES2163529T3 (de)
IL (1) IL116065A (de)
PT (1) PT793665E (de)
TW (1) TW390883B (de)
WO (1) WO1996016065A1 (de)
ZA (1) ZA959834B (de)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4217356A (en) * 1975-08-22 1980-08-12 Sandoz Ltd. 2-Imidazolinylamino-2,1,3-benzothiadiazoles
US4352809A (en) * 1981-09-04 1982-10-05 Smithkline Corporation Method of producing alpha2 antagonism
SU1122659A1 (ru) * 1983-05-27 1984-11-07 Новокузнецкий научно-исследовательский химико-фармацевтический институт Производные/1,2,5/тиадиазоло/3,4- @ /индолов и способ их получени
US4673680A (en) * 1985-09-18 1987-06-16 Pendleton Robert G α2 -adrenergic receptor antagonists as modifiers of gastrointestinal motility
DK198590D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
US5171861A (en) * 1990-10-29 1992-12-15 Mobil Oil Corporation Thiadiazole-aryl sulfonate reaction products as multifunctional additives and compositions containing same
JP2990307B2 (ja) * 1991-05-15 1999-12-13 コニカ株式会社 電子写真感光体

Also Published As

Publication number Publication date
EP0793665A1 (de) 1997-09-10
ES2163529T3 (es) 2002-02-01
WO1996016065A1 (en) 1996-05-30
DE69522706D1 (de) 2001-10-18
DK0793665T3 (da) 2001-12-31
IL116065A0 (en) 1996-01-31
ZA959834B (en) 1996-07-02
ATE205499T1 (de) 2001-09-15
PT793665E (pt) 2002-02-28
AU3978095A (en) 1996-06-17
US5741788A (en) 1998-04-21
TW390883B (en) 2000-05-21
EP0793665B1 (de) 2001-09-12
JPH10509154A (ja) 1998-09-08
DE69522706T2 (de) 2002-07-11

Similar Documents

Publication Publication Date Title
AU662105B2 (en) Derivatives and azabicyclic oxadiazole or thiadiazole compounds
EP0544714B1 (de) Heterozyklische verbindungen, ihre herstellung und anwendung
WO1994013663A1 (en) Aminomethylene substituted non-aromatic heterocycles and use as substance p antagonists
US5414009A (en) Azabicyclo substituted oxa- or thia-diazole compounds
EP0811008A1 (de) Bicyclische benzazepin-derivate als vasopressin-antagonisten
JP2001520231A (ja) ベンゾオキサジン誘導体、その製造およびその治療における適用
CZ75496A3 (en) Piperidine derivatives, process of their preparation, said derivatives as medicaments and pharmaceutical composition containing such derivatives
EP0349956A1 (de) Azacyclische Verbindungen, ihre Herstellung und Verwendung
FI94131B (fi) Menetelmä valmistaa terapeuttisesti aktiivisia R(-)-3-kinuklidinolijohdannaisia
US5200415A (en) Pyrazolo[1,5-a]pyridine-3-carboxylic acid derivatives and their pharmaceutical use
US5527813A (en) Heterocyclic compounds and their preparation and use
US5637596A (en) Azabicycloalkyl derivatives of imidazo[1,5-a]indol-3-one and process for their preparation
IL116065A (en) Polycyclic 1, 2, 5-thiadiazole compounds, their preparation and pharmaceutical compositions containing them
AU742666B2 (en) 5-aryl-3-(8-azabicyclo(3.2.1)oct-3-YL)-1,3,4-oxadiazol-2 (3H)-one derivatives as 5-HT4 receptor ligands
US5641791A (en) Heterocyclic compounds and their preparation and use
US5914338A (en) Heterocyclic compounds and their preparation and use
US6369074B1 (en) Aminomethylene substituted non-aromatic heterocycles and use as substance P antagonists
US5854262A (en) Aminomethylene substituted non-aromatic heterocycles and use as substance P antagonists
US20030162766A1 (en) Aminomethylene substituted non-aromatic heterocycles and use as substance P antagonists
US5994373A (en) Substituted azacyclic compounds

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed